Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Other solid neoplasm 1NET 1Gynecologic 1Gastrointestinal 1Endocrine 1CNS 1

Conditions

Sarcoma 4Sarcoma, Ewing 3Neoplasms 3Stomach Neoplasms 1Neuroendocrine Tumors 1Mesothelioma 1Leiomyosarcoma 1Glioblastoma 1Gastro-enteropancreatic neuroendocrine tumor 1Endometrial Neoplasms 1Desmoplastic Small Round Cell Tumor 1Colorectal Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Filgrastim 5Peripheral Blood Stem Cell Transplantation 4Cyclophosphamide 4Radiotherapy 3Polymerase Chain Reaction 3Paclitaxel 3Cisplatin 3Carboplatin 3Amplified Fragment Length Polymorphism Analysis 3Amifostine 3aflibercept 2Therapeutics 2Itraconazole 2Irinotecan 2Ifosfamide 2Gene Expression Profiling 2Flow Cytometry 2Fentanyl 2Etoposide 2Docetaxel 2tislelizumab 1thymoglobulin 1talazoparib 1spartalizumab 1sargramostim 1motexafin lutetium 1liposomal amphotericin B 1fludarabine 1etoposide phosphate 1entinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Ovarian Epithelial × PM 01183 × Sarcoma × Clear all
NCT02611024 2025-07-09

Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors

PharmaMar

Phase 1/2 Completed
316 enrolled
CNSEndocrineGastrointestinalGynecologicNETOther solid neoplasmSarcomaThoracic

Gastro-enteropancreatic neuroendocrine tumor, Carcinoma, Ovarian Epithelial, Glioblastoma, Mesothelioma, Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡